When California biotech company Second Sight ran out of money in 2020, the future looked dim for hundreds of blind users around the world relying on its Argus II retinal implant, or its next-generation Orion brain implant, for some approximation of vision.Last year, IEEE Spectrum documented the journeys of users as they attempted to get support for their tiny implants…
Read More
About The Author
